Transdermal lisuride: a double-blind, randomized, active- and placebo-controlled multi-centre phase III efficacy trial for the treatment of patients with restless legs syndrome (RLS).

Trial Profile

Transdermal lisuride: a double-blind, randomized, active- and placebo-controlled multi-centre phase III efficacy trial for the treatment of patients with restless legs syndrome (RLS).

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Mar 2012

At a glance

  • Drugs Lisuride; Ropinirole
  • Indications Restless legs syndrome
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 06 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Jun 2008 Axxonis submitted MAA to EMEA for transdermal lisuride as add-on therapy for Parkinson's Disease and Restless Legs Syndrome.
    • 10 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top